+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

, : Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers. Acta Oncologica 51(2): 234-242

Patients with upper gastrointestinal cancers have a poor prognosis and only few treatment options. The epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) are valid targets in many solid tumours, and they have synergistic effects in preclinical studies. In this multi-center phase II trial patients with chemoresistant, metastatic upper gastrointestinal cancer were treated with erlotinib (150 mg daily) and bevacizumab (10 mg/kg every two weeks). Primary endpoint was overall response rate (ORR). Secondary endpoints were progression free survival (PFS), overall survival (OS), toxicity and biomarker correlates. Plasma samples were analysed for EGFR and angiogenesis related markers using quantitative immunoassays. One hundred and two patients were enrolled in the trial between June 2006 and October 2007. The most common toxicities were skin reaction, diarrhoea, and fatigue. ORR was 6%, median PFS was 2.2 months, and OS 4.3 months. Low concentration of urokinase plasminogen activator receptor (uPAR) domain I was correlated to longer PFS and OS. The combination of erlotinib and bevacizumab is well tolerated, however, with low clinical activity in patients with chemoresistant UGI cancer. Some patients do benefit from the therapy, and uPAR forms are potential biomarkers in these patients.


PMID: 22017239

DOI: 10.3109/0284186X.2011.619568

Other references

Severi, S.; Bolasco, P.; Badiali, F.; Concas, G.; Mancini, E.; Summa, A.; Perazzini, C.; Steckiph, D.; Cagnoli, L.; Santoro, A., 2014: Calcium profiling in hemodiafiltration: a new way to reduce the calcium overload risk without compromising cardiovascular stability. Low and high dialysate calcium (Ca²⁺) content may have positive and harmful effects depending on the considered pathological aspect: hemodynamic instability, cardiac arrhythmias, parathormone release, adynamic bone disease, cardio-vascular calc...

Ambrad, J., 2013: Solo practice can equal happiness. Family Practice Management 19(6): 6-6

Alexander, C.S.; Swingle, K.F.; Nagasawa, H.T., 1966: Teratogenlc effect of puromycin aminonucleoside on rat kidney. The aminonucleoside of puromycin (PA) was administered to pregnant rats during early, mid- and late pregnancy. Abnormal nephrogenic development occurred in 20% of newborn rats of mothers treated with PA on the 8th, 9th and 10th days of pregnancy,...

Nam, J.; Huang, Y.; Agarwal, S.; Lannutti, J., 2007: Improved cellular infiltration in electrospun fiber via engineered porosity. Small pore sizes inherent to electrospun matrices can hinder efficient cellular ingrowth. To facilitate infiltration while retaining its extracellular matrix-like character, electrospinning was combined with salt leaching to produce a scaffold hav...

Tominari, T.; Hirata, M.; Matsumoto, C.; Inada, M.; Miyaura, C., 2013: Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis. Nobiletin, a polymethoxy flavonoid (PMF), inhibits systemic bone resorption and maintains bone mass in estrogen-deficient ovariectomized mice. This study examined the anti-inflammatory effects of PMFs, nobiletin, and tangeretin on lipopolysacchari...

Mertie John Beaver Jr., 1913: Igneous rocks of the Raton Mesa region. Journal of the Washington Academy of Sciences 3: 302

D'addario, V.; Resta, M.; Greco, P.; Caruso, G., 1993: TVS and MRI New techniques of evaluation of fetal brain anomalies. Fetal Diagnosis & Therapy 8(SUPPL 2): 6

Puius, Y.A.; Zou, M.; Ho, N.T.; Ho, C.; Almo, S.C., 1998: Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(alpha 96Val-->Trp). One of the most promising approaches for the development of a synthetic blood substitute has been the engineering of novel mutants of human hemoglobin (Hb) A which maintain cooperativity, but possess lowered oxygen affinity. We describe here two c...

Vorob'ev, A.A.; Podkuĭko, V.N.; Mikhaĭlov, V.V., 2002: Results of basic and applied investigations on oral immunization against smallpox. The results of fundamental and applied investigations on the development and trial of the oral administration of smallpox vaccine and live recombinant smallpox-hepatitis vaccine (Revax VT) in tablets are summarized. In comparative experiments on a...

Robinson J.W.L.; Van Melle G., 1982: Single site uptake of mono saccharides by guinea pig small intestine. Experientia (Basel) 38(6): 718